How eliminating malaria may also prevent iron deficiency in African children

Pharmaceuticals

Volumn 11, Issue 4, 2018, Pages

  Muriuki, John Muthii ^a   Atkinson, Sarah H ^a,b,c  

^a University of Oxford ^*  (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Africa; Children; Hepcidin; Iron deficiency; Malaria; TNF

Indexed keywords

HEPCIDIN; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; TUMOR NECROSIS FACTOR;

AFRICAN; CHILD; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; HEALTH PROGRAM; HIGH RISK PATIENT; HORMONE BLOOD LEVEL; HUMAN; IRON DEFICIENCY; MALARIA; MALARIA CONTROL; NUTRITIONAL STATUS; PARASITE CLEARANCE; PARASITE TRANSMISSION; PROTEIN EXPRESSION; PUBLIC HEALTH; REVIEW; RISK ASSESSMENT; RISK REDUCTION;

EID: 85055747144     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph11040096     Document Type: Review

References (81)

1. Kyu, H.H.; Pinho, C.; Wagner, J.A.; Brown, J.C.; Bertozzi-Villa, A.; Charlson, F.J.; Coffeng, L.E.; Dandona, L.; Erskine, H.E.; Ferrari, A.J.; et al. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013. JAMA Pediatr. 2016, 170, 267. [CrossRef] [PubMed]
2. World Health Organization. World Malaria Report 2017; World Health Organization: Geneva, Switzerland, 2017; ISBN 9789241565523.
3. World Health Organization. World Malaria Report 2015; World Health Organization: Geneva, Switzerland, 2015; ISBN 978 92 4 1564403.
4. Snow, R.W.; Sartorius, B.; Kyalo, D.; Maina, J.; Amratia, P.; Mundia, C.W.; Bejon, P.; Noor, A.M. The Prevalence of Plasmodium Falciparum in Sub-Saharan Africa Since 1900. Nature 2017, 550, 515-518. [CrossRef] [PubMed]
5. Kassebaum, N.J.; Jasrasaria, R.; Naghavi, M.; Wulf, S.K.; Johns, N.; Lozano, R.; Regan, M.; Weatherall, D.; Chou, D.P.; Eisele, T.P. et al. A Systematic Analysis of Global Anemia Burden from 1990 to 2010. Blood J. 2014, 123, 615-625. [CrossRef] [PubMed]
6. Mwangi, M.N.; Phiri, K.S.; Abkari, A.; Gban, M.; Bourdet-sicard, R.; Braesco, A.; Zimmermann, M.B.; Prentice, A.M. Iron for Africa—Report of an Expert Workshop. Nutrients 2017, 9, 576. [CrossRef] [PubMed]
7. Doom, J.R.; Georgieff, M.K. Striking While the Iron is Hot: Understanding the Biological and Neurodevelopmental Effects of Iron Deficiency to Optimize Intervention in Early Childhood. Curr. Pediatr. Rep. 2014, 2, 291-298. [CrossRef] [PubMed]
8. Lozoff, B. Early Iron Deficiency Has Brain and Behavior Effects Consistent with Dopaminergic Dysfunction. J. Nutr. 2011, 141, 740-746. [CrossRef] [PubMed]
9. Beard, J. Recent Evidence from Human and Animal Studies Regarding Iron Status and Infant Development. J. Nutr. 2007, 137, 524S-530S. [CrossRef] [PubMed]
10. Suchdev, P.; Leeds, I.; McFarland, D.; Flores, R. Is It Time to Change Guidelines for Iron Supplementation in Malarial Areas? J. Nutr. 2010, 140, 875-876. [CrossRef] [PubMed]
11. Brittenham, G.M. Safety of Iron Fortification and Supplementation in Malaria-Endemic Areas. Nestle Nutr. Inst. Work. Ser. 2012, 70, 117-127. [CrossRef]
12. Sazawal, S.; Black, R.; Ramsan, M.; Chwaya, H.; Stoltzfus, R.; Dutta, A.; Dhingra, U.; Kabole, I.; Deb, S.; Othman, M.; et al. Effect of Routine Prophylactic Supplementation with Iron and Folic Acid on Admission to Hospital and Mortality in Preschool Children in a High Malaria Transmission Setting: Community Based, Randomised, Placebo-Controlled Trial. Lancet 2006, 367, 133-143. [CrossRef]
13. Verhoef, H.; West, C.E.; Nzyuko, S.M.; de Vogel, S.; van der Valk, R.; Wanga, M.A.; Kuijsten, A.; Veenemans, J.; Kok, F.J. Intermittent Administration of Iron and Sulfadoxine-Pyrimethamine to Control Anaemia in Kenyan Children: A Randomised Controlled Trial. Lancet 2002, 360, 908-914. [CrossRef]
14. Desai, M.R.; Mei, J.V.; Kariuki, S.K.; Wannemuehler, K.A.; Phillips-Howard, P.A.; Nahlen, B.L.; Kager, P.A.; Vulule, J.M.; ter Kuile, F.O. Randomized, Controlled Trial of Daily Iron Supplementation and Intermittent Sulfadoxine-Pyrimethamine for the Treatment of Mild Childhood Anemia in Western Kenya. J. Infect. Dis. 2003, 187, 658-666. [CrossRef] [PubMed]
15. Ouédraogo, H.Z.; Dramaix-Wilmet, M.; Zeba, A.N.; Hennart, P.; Donnen, P. Effect of Iron or Multiple Micronutrient Supplements on the Prevalence of Anaemia Among Anaemic Young Children of a Malaria-Endemic Area: A Randomized Double-Blind Trial. Trop. Med. Int. Health 2008, 13, 1257-1266. [CrossRef] [PubMed]
16. Zlotkin, S.; Newton, S.; Aimone, A.M.; Azindow, I.; Amenga-Etego, S.; Tchum, K.; Mahama, E.; Thorpe, K.E.; Owusu-Agyei, S. Effect of Iron Fortification on Malaria Incidence in Infants and Young Children in Ghana: A Randomized Trial. JAMA 2013, 310, 938-947. [CrossRef] [PubMed]
17. Neuberger, A.; Okebe, J.; Yahav, D.; Paul, M. Oral Iron Supplements for Children in Malaria-Endemic Areas. Cochrane Database Syst. Rev. 2016. [CrossRef] [PubMed]
18. World Health Organization. Guideline: Daily Iron Supplementation in Infants and Children; World Health Organization: Geneva, Switzerland, 2016.
19. Nyakeriga, A.M.; Troye-blomberg, M.; Chemtai, A.K.; Marsh, K.; Williams, T.N. Iron Deficiency and Malaria among Children Living on the Coast of Kenya. J. Infect. Dis. 2004, 190, 439-447. [CrossRef] [PubMed]
20. Gwamaka, M.; Kurtis, J.D.; Sorensen, B.E.; Holte, S.; Morrison, R.; Mutabingwa, T.K.; Fried, M.; Duffy, P.E. Iron Deficiency Protects Against Severe Plasmodium Falciparum Malaria and Death in Young Children. Clin. Infect. Dis. 2012, 54, 1137-1144. [CrossRef] [PubMed]
21. Jonker, F.A.M.; Calis, J.C.J.; van Hensbroek, M.B.; Phiri, K.; Geskus, R.B.; Brabin, B.J.; Leenstra, T. Iron Status Predicts Malaria Risk in Malawian Preschool Children. PLoS ONE 2012, 7, 1-8. [CrossRef] [PubMed]
22. Moya-Alvarez, V.; Cottrell, G.; Ouedraogo, S.; Accrombessi, M.; Massougbodgi, A.; Cot, M. High Iron Levels Are Associated with Increased Malaria Risk in Infants during the First Year of Life in Benin. Am. J. Trop. Med. Hyg. 2017, 97, 497-503. [CrossRef] [PubMed]
23. Muriuki, J.M.; Mentzer, A.J.; Kimita, W.; Ndungu, F.M.; Macharia, A.W.; Webb, E.L.; Lule, S.A.; Morovat, A.; Hill, A.V.S.; Bejon, P.; et al. Iron Status and Associated Malaria Risk Among African Children. Clin. Infect. Dis. 2018. [CrossRef] [PubMed]
24. Glinz, D.; Hurrell, R.F.; Righetti, A.A.; Zeder, C.; Adiossan, L.G.; Tjalsma, H.; Utzinger, J.; Zimmermann, M.B.; N’Goran, E.K.; Wegmüller, R. In Ivorian School-Age Children, Infection with Hookworm Does Not Reduce Dietary Iron Absorption or Systemic Iron Utilization, Whereas Afebrile Plasmodium Falciparum Infection Reduces Iron Absorption By Half. Am. J. Clin. Nutr. 2015, 101, 462-470. [CrossRef] [PubMed]
25. Paganini, D.; Zimmermann, M.B. Effects of Iron Fortification and Supplementation on the Gut Microbiome and Diarrhea in Infants and Children: A Review. Am. J. Clin. Nutr. 2017, 106, 1688S-1693S. [CrossRef] [PubMed]
26. Baliraine, F.N.; Afrane, Y.A.; Amenya, D.A.; Bonizzoni, M.; Menge, D.M.; Zhou, G.; Zhong, D.; Vardo-Zalik, A.M.; Githeko, A.K.; Yan, G. High Prevalence of Asymptomatic Plasmodium Falciparum Infections in a Highland Area of Western Kenya: A Cohort Study. J. Infect. Dis. 2009, 200, 66-74. [CrossRef] [PubMed]
27. Howard, C.T.; McKakpo, U.S.; Quakyi, I.A.; Bosompem, K.M.; Addison, E.A.; Sun, K.; Sullivan, D.; Semba, R.D. Relationship of Hepcidin with Parasitemia and Anemia Among Patients with Uncomplicated Plasmodium Falciparum Malaria in Ghana. Am. J. Trop. Med. Hyg. 2007, 77, 623-626. [CrossRef] [PubMed]
28. De Mast, Q.; Nadjm, B.; Reyburn, H.; Kemna, E.H.J.M.; Amos, B.; Laarakkers, C.M.M.; Silalye, S.; Verhoef, H.; Sauerwein, R.W.; Swinkels, D.W.; et al. Assessment of Urinary Concentrations of Hepcidin Provides Novel Insight into Disturbances in Iron Homeostasis during Malarial Infection. J. Infect. Dis. 2009, 199, 253-262. [CrossRef] [PubMed]
29. Casals-Pascual, C.; Huang, H.; Lakhal-Littleton, S.; Thezenas, M.L.; Kai, O.; Newton, C.R.J.C.; Roberts, D.J. Hepcidin Demonstrates a Biphasic Association with Anemia in Acute Plasmodium Falciparum Malaria. Haematologica 2012, 97, 1695-1698. [CrossRef] [PubMed]
30. Ayoya, M.A.; Stoltzfus, R.J.; Nemeth, E.; Traoré, A.K.; Ganz, T. Hepcidin and Plasmodium Falciparum Malaria in Anemic School Children in Mali. Bull. Soc. Pathol. Exot. 2009, 120, 219-220.
31. Atkinson, S.H.; Uyoga, S.M.; Armitage, A.E.; Khandwala, S.; Mugyenyi, C.K.; Bejon, P.; Marsh, K.; Beeson, J.G.; Prentice, A.M.; Drakesmith, H.; et al. Malaria and Age Variably but Critically Control Hepcidin Throughout Childhood in Kenya. EBIOM 2015, 2, 1478-1486. [CrossRef] [PubMed]
32. de Mast, Q.; Syafruddin, D.; Keijmel, S.; Riekerink, T.O.; Deky, O.; Asih, P.B.; Swinkels, D.W.; van der Ven, A.J. Increased Serum Hepcidin and Alterations in Blood Iron Parameters Associated with Asymptomatic P. Falciparum and P. Vivax Malaria. Haematologica 2010, 95, 1068-1074. [CrossRef] [PubMed]
33. Cercamondi, C.I.; Egli, I.M.; Ahouandjinou, E.; Dossa, R.; Zeder, C.; Salami, L.; Tjalsma, H.; Wiegerinck, E.; Tanno, T.; Hurrell, R.F.; et al. Afebrile Plasmodium Falciparum Parasitemia Decreases Absorption of Fortification Iron but does not Affect Systemic Iron Utilization: A Double Stable-Isotope Study in Young Beninese Women. Am. J. Clin. Nutr. 2010, 92, 1385-1392. [CrossRef] [PubMed]
34. Spottiswoode, N.; Armitage, A.E.; Williams, A.R.; Fyfe, A.J.; Biswas, S.; Hodgson, S.H.; Llewellyn, D.; Choudhary, P.; Draper, S.J.; Duffy, P.E.; et al. Role of Activins in Hepcidin Regulation During Malaria. Infect. Immun. 2017, 85, 1-17. [CrossRef] [PubMed]
35. Nemeth, E.; Tuttle, M.S.; Powelson, J.; Vaughn, M.B.; Donovan, A.; Ward, D.M.; Ganz, T.; Kaplan, J. Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization. Science 2004, 306, 2090-2093. [CrossRef] [PubMed]
36. Abboud, S.; Haile, D.J. A Novel Mammalian Iron-Regulated Protein Involved in Intracellular Iron Metabolism. J. Biol. Chem. 2000, 275, 19906-19912. [CrossRef] [PubMed]
37. Yang, F.; Liu, X.B.; Quinones, M.; Melby, P.C.; Ghio, A.; Haile, D.J. Regulation of Reticuloendothelial Iron Transporter MTP1 (Slc11a3) by Inflammation. J. Biol. Chem. 2002, 277, 39786-39791. [CrossRef] [PubMed]
38. Donovan, A.; Brownlie, A.; Zhou, Y.; Shepard, J.; Pratt, S.J.; Moynihan, J.; Paw, B.H.; Drejer, A.; Barut, B.; Zapata, A.; et al. Positional Cloning of Zebrafish Ferroportin1 Identifies a Conserved Vertebrate Iron Exporter. Nature 2000, 403, 776-781. [CrossRef] [PubMed]
39. McKie, A.T.; Marciani, P.; Rolfs, A.; Brennan, K.; Wehr, K.; Barrow, D.; Miret, S.; Bomford, A.; Peters, T.J.; Farzaneh, F.; et al. A Novel Duodenal Iron-Regulated Transporter, IREG1, Implicated in the Basolateral Transfer of Iron to the Circulation. Mol. Cell 2000, 5, 299-309. [CrossRef]
40. Zhang, D.L.; Wu, J.; Shah, B.N.; Greutélaers, K.C.; Ghosh, M.C.; Ollivierre, H.; Su, X.Z.; Thuma, P.E.; Bedu-Addo, G.; Mockenhaupt, F.P.; et al. Erythrocytic Ferroportin Reduces Intracellular Iron Accumulation, Hemolysis, and Malaria Risk. Science 2018, 359, 1520-1523. [CrossRef] [PubMed]
41. Mena, N.P.; Esparza, A.; Tapia, V.; Valdés, P.; Núñez, M.T. Hepcidin Inhibits Apical Iron Uptake in Intestinal Cells. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 294, G192-G198. [CrossRef] [PubMed]
42. Brasselagnel, C.; Karim, Z.; Letteron, P.; Bekri, S.; Bado, A.; Beaumont, C. Intestinal DMT1 Cotransporter is Down-Regulated by Hepcidin via Proteasome Internalization and Degradation. Gastroenterology 2011, 140, 1261-1271. [CrossRef] [PubMed]
43. Kwiatkowski, D.; Sambou, I.; Twumasi, P.; Greenwood, B.M.; Hill, A.V.S.; Manogue, K.R.; Cerami, A.; Castracane, J.; Brewster, D.R. TNF Concentration in Fatal Cerebral, Non-Fatal Cerebral, AND Uncomplicated Plasmodium Falciparum Malaria. Lancet 1990, 336, 1201-1204. [CrossRef]
44. Kurtzhals, J.A.L.; Addae, M.M.; Akanmori, B.D.; Dunyo, S.; Koram, K.A.; Appawu, M.A.; Nkrumah, F.K.; Hviid, L. Anaemia Caused by Asymptomatic PIasmodium Falciparum Infection in Semi-Immune African Schoolchildren. Trans. R. Soc. Trop. Med. Hyg. 1999, 93, 623-627. [CrossRef]
45. Alvarez-Hernández, X.; Licéaga, J.; McKay, I.C.; Brock, J.H. Induction of Hypoferremia and Modulation of Macrophage Iron Metabolism by Tumor Necrosis Factor. Lab. Investig. 1989, 61, 319-322. [PubMed]
46. Roodman, G.; Bird, A.; Hutzler, D.; Montgomery, W. Tumor Necrosis Factor-Alpha and Hematopoietic Progenitors: Effects of Tumor Necrosis Factor on the Growth of Erythroid Progenitors CFU-E and BFU-E and the Hematopoietic Cell Lines K562, HL60, and HEL Cells. Exp. Hematol. 1987, 15, 928-935. [PubMed]
47. Johnson, D.; Bayele, H.; Johnston, K.; Tennant, J.; Srai, S.K.; Sharp, P. Tumour Necrosis Factor Alpha Regulates Iron Transport and Transporter Expression in Human Intestinal Epithelial Cells. FEBS Lett. 2004, 573, 195-201. [CrossRef] [PubMed]
48. Laftah, A.H.; Sharma, N.; Brookes, M.J.; McKie, A.T.; Simpson, R.J.; Iqbal, T.H.; Tselepis, C. Tumour Necrosis Factor Alpha Causes Hypoferraemia and Reduced Intestinal Iron Absorption in Mice. Biochem. J. 2006, 397, 61-67. [CrossRef] [PubMed]
49. Kroeger, K.M.; Carville, K.S.; Abraham, L.J. The −308 Tumor Necrosis Factor-a Promotor Polymorphism Effects Transcription. Mol. Immunol. 1997, 34, 391-399. [CrossRef]
50. Wilson, A.G.; Symons, J.A.; McDowell, T.L.; McDevitt, H.O.; Duff, G.W. Effects of a Polymorphism in the Human Tumor Necrosis Factor Alpha Promoter on Transcriptional Activation. Proc. Natl. Acad. Sci. USA 1997, 94, 3195-3199. [CrossRef] [PubMed]
51. Atkinson, S.H.; Rockett, K.A.; Morgan, G.; Bejon, P.A.; Sirugo, G.; O’Connell, M.A.; Hanchard, N.; Kwiatkowski, D.P.; Prentice, A.M. Tumor Necrosis Factor SNP Haplotypes are Associated with Iron Deficiency Anemia in West African Children. Blood 2008, 112, 4276. [CrossRef] [PubMed]
52. Atkinson, S.H.; Armitage, A.E.; Khandwala, S.; Mwangi, T.W.; Uyoga, S.; Bejon, P.A.; Williams, T.N.; Prentice, A.M.; Drakesmith, H. Combinatorial Effects of Malaria Season, Iron Deficiency, and Inflammation Determine Plasma Hepcidin Concentration in African Children. Blood 2014, 123, 3221-3229. [CrossRef] [PubMed]
53. Frosch, A.E.P.; Ondigo, B.N.; Ayodo, G.A.; Vulule, J.M.; John, C.C.; Cusick, S.E. Decline in Childhood Iron Deficiency after Interruption of Malaria Transmission in Highland Kenya. Am. J. Clin. Nutr. 2014, 100, 968-973. [CrossRef] [PubMed]
54. Meremikwu, M.; Donegan, S.; Sinclair, D.; Esu, E.; Oringanje, C. Intermittent Preventive Treatment for Malaria in Children Living in Areas with Seasonal Transmission (Review). Cochrane Database Syst. Rev. 2012. [CrossRef] [PubMed]
55. Nairz, M.; Theurl, I.; Wolf, D.; Weiss, G. Iron Deficiency or Anemia of Inflammation? Wien. Med. Wochenschr. 2016, 166, 411-423. [CrossRef] [PubMed]
56. Pasricha, S.R.; Atkinson, S.H.; Armitage, A.E.; Khandwala, S.; Veenemans, J.; Cox, S.E.; Eddowes, L.A.; Hayes, T.; Doherty, C.P.; Demir, A.Y.; et al. Expression of the Iron Hormone Hepcidin Distinguishes Different Types of Anemia in African Children. Sci. Transl. Med. 2014, 6. [CrossRef] [PubMed]
57. Suchdev, P.S.; Williams, A.M.; Mei, Z.; Flores-ayala, R.; Pasricha, S.; Rogers, L.M. Assessment of Iron Status in Settings of Inflammation: Challenges and Potential Approaches. Am. J. Clin. Nutr. 2017, 106, 1626-1633. [CrossRef] [PubMed]
58. Bejon, P.; Warimwe, G.; Mackintosh, C.L.; Mackinnon, M.J.; Kinyanjui, S.M.; Musyoki, J.N.; Bull, P.C.; Marsh, K. Analysis of Immunity to Febrile Malaria in Children that Distinguishes Immunity from Lack of Exposure. Infect. Immun. 2009, 77, 1917-1923. [CrossRef] [PubMed]
59. Langhorne, J.; Ndungu, F.M.; Sponaas, A.-M.; Marsh, K. Immunity to Malaria: More Questions Than Answers. Nat. Immunol. 2008, 9, 725-732. [CrossRef] [PubMed]
60. Olotu, A.; Fegan, G.; Wambua, J.; Nyangweso, G.; Ogada, E.; Drakeley, C.; Marsh, K.; Bejon, P. Estimating Individual Exposure to Malaria Using Local Prevalence of Malaria Infection in the Field. PLoS ONE 2012, 7. [CrossRef] [PubMed]
61. Noor, A.M.; Kinyoki, D.K.; Mundia, C.W.; Kabaria, C.W.; Mutua, J.W.; Alegana, V.A.; Fall, I.S.; Snow, R.W. The Changing Risk of Plasmodium Falciparum Malaria Infection in Africa: 2000-10: A Spatial And Temporal Analysis of Transmission Intensity. Lancet 2014, 383, 1739-1747. [CrossRef]
62. Das, B.S.; Thurnham, D.I.; Das, D.B. Influence of Malaria on Markers of Iron Status in Children: Implications for Interpreting Iron Status in Malaria-Endemic Communities. Br. J. Nutr. 1997, 78, 751-760. [CrossRef] [PubMed]
63. Phiri, K.S.; Calis, J.C.J.; Siyasiya, A.; Bates, I.; Brabin, B.; van Hensbroek, M.B. New Cut-Off Values for Ferritin and Soluble Transferrin Receptor for the Assessment of Iron Deficiency in Children in a High Infection Pressure Area. J. Clin. Pathol. 2009, 62, 1103-1106. [CrossRef] [PubMed]
64. Aguilar, R.; Moraleda, C.; Quintó, L.; Renom, M.; Mussacate, L.; Macete, E.; Aguilar, J.L.; Alonso, P.L.; Menéndez, C. Challenges in the Diagnosis of Iron Deficiency in Children Exposed to High Prevalence of Infections. PLoS ONE 2012, 7, 3-9. [CrossRef] [PubMed]
65. Glinz, D.; Hurrell, R.F.; Ouattara, M.; Zimmermann, M.B.; Brittenham, G.M.; Adiossan, L.G.; Righetti, A.A.; Seifert, B.; Diakité, V.G.; Utzinger, J.; et al. The Effect of Iron—Fortified Complementary Food and Intermittent Preventive Treatment of Malaria on Anaemia in 12-to 36-Month-Old Children: A Cluster-Randomised Controlled Trial. Malar. J. 2015, 1-12. [CrossRef] [PubMed]
66. Smith, G.D.; Ebrahim, S. “Mendelian randomization”: Can Genetic Epidemiology Contribute to Understanding Environmental Determinants of Disease? Int. J. Epidemiol. 2003, 32, 1-22. [CrossRef] [PubMed]
67. Evans, D.M.; Davey Smith, G. Mendelian Randomization: New Applications in the Coming Age of Hypothesis-Free Causality. Annu. Rev. Genom. Hum. Genet. 2015, 16, 327-350. [CrossRef] [PubMed]
68. Afzal, S.; Brøndum-Jacobsen, P.; Bojesen, S.E.; Nordestgaard, B.G. Genetically Low Vitamin D Concentrations and Increased Mortality: Mendelian Randomisation Analysis in Three Large Cohorts. BMJ 2014, 349, g6330. [CrossRef] [PubMed]
69. Voight, B.F.; Peloso, G.M.; Orho-Melander, M.; Frikke-Schmidt, R.; Barbalic, M.; Jensen, M.K.; Hindy, G.; Hólm, H.; Ding, E.L.; Johnson, T.; et al. Plasma HDL Cholesterol and Risk of Myocardial Infarction: A Mendelian Randomisation Study. Lancet 2012, 380, 572-580. [CrossRef]
70. Elliott, P.; Chambers, J.C.; Zhang, W.; Clarke, R.; Hopewell, J.C.; Peden, J.F.; Erdmann, J.; Braund, P.; Engert, J.C.; Bennett, D.; et al. Genetic Loci Associated with C-Reactive Protein Levels and Risk of Coronary Heart Disease. J. Am. Med. Assoc. 2009, 302, 37-48. [CrossRef] [PubMed]
71. Williams, T.N.; Mwangi, T.W.; Wambua, S.; Alexander, N.D.; Kortok, M.; Snow, R.W.; Marsh, K. Sickle Cell Trait and the Risk of Plasmodium falciparum Malaria and Other Childhood Diseases. J. Infect. Dis. 2005, 192, 178-186. [CrossRef] [PubMed]
72. Malaria Genomic Epidemiology Network. Reappraisal of Known Malaria Resistance Loci in a Large Multicenter Study. Nat. Genet. 2014, 46, 1197-1204. [CrossRef] [PubMed]
73. Bowden, J.; Smith, G.D.; Burgess, S. Mendelian Randomization with Invalid Instruments: Effect Estimation and Bias Detection Through Egger Regression. Int. J. Epidemiol. 2015, 44, 512-525. [CrossRef] [PubMed]
74. Burgess, S.; Butterworth, A.; Thompson, S.G. Mendelian Randomization Analysis with Multiple Genetic Variants Using Summarized Data. Genet. Epidemiol. 2013, 37, 658-665. [CrossRef] [PubMed]
75. Sheehan, N.A.; Didelez, V.; Burton, P.R.; Tobin, M.D. Mendelian Randomisation and Causal Inference in Observational Epidemiology. PLoS Med. 2008, 5, 1205-1210. [CrossRef] [PubMed]
76. Gera, T.; Sachdev, H.; Nestel, P.; Sachdev, S.S. Effect of Iron Supplementation on Haemoglobin Response in Children: Systematic Review of Randomised Controlled Trials. J. Pediatr. Gastroenterol. Nutr. 2007, 44, 468-486. [CrossRef] [PubMed]
77. Doherty, C.P.; Cox, S.E.; Fulford, A.J.; Austin, S.; Hilmers, D.C.; Abrams, S.A.; Prentice, A.M. Iron Incorporation and Post-Malaria Anaemia. PLoS ONE 2008, 3. [CrossRef] [PubMed]
78. Prentice, A.M.; Doherty, C.P.; Abrams, S.A.; Cox, S.E.; Atkinson, S.H.; Verhoef, H.; Armitage, A.E.; Drakesmith, H. Hepcidin is the Major Predictor of Erythrocyte Iron Incorporation in Anemic African Children. Blood 2012, 119, 1922-1928. [CrossRef] [PubMed]
79. Zimmermann, M.B.; Chassard, C.; Rohner, F.; Goran, K.N.E.; Nindjin, C.; Dostal, A.; Utzinger, J.; Ghattas, H.; Lacroix, C.; Hurrell, R.F. The Effects of Iron Fortification on the Gut Microbiota in African Children: A Randomized Controlled Trial in Cote d’Ivoire. Am. J. Clin. Nutr. 2010, 92, 1406-1415. [CrossRef] [PubMed]
80. Jaeggi, T.; Kortman, G.A.M.; Moretti, D.; Chassard, C.; Holding, P.; Dostal, A.; Boekhorst, J.; Timmerman, H.M.; Swinkels, D.W.; Tjalsma, H.; et al. Iron Fortification Adversely Affects the Gut Microbiome, Increases Pathogen Abundance and Induces Intestinal Inflammation in Kenyan Infants. Gut 2015, 64, 731-742. [CrossRef] [PubMed]
81. Tang, M.; Frank, D.N.; Hendricks, A.E.; Ir, D.; Esamai, F.; Liechty, E.; Hambidge, K.M.; Krebs, N.F. Iron in Micronutrient Powder Promotes an Unfavorable Gut Microbiota in Kenyan Infants. Nutrients 2017, 9, 776. [CrossRef] [PubMed]